Litigation Details for BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,. (D.N.J. 2015)
✉ Email this page to a colleague
BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,. (D.N.J. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-07-31 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:145 Patent Infringement | Assigned To | Kevin McNulty |
| Jury Demand | None | Referred To | William Clark |
| Patents | 8,022,082; 8,822,438 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-03-08 | 176 | Motion for Miscellaneous Relief | Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 by BTG INTERNATIONAL LIMITED, JANSSEN BIOTECH… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey | External link to document |
| 2016-03-08 | 179 | Certificate of Service | Hearing And Correct Inventorship of U.S. Patent No. 8,822,438, 178 MOTION to Seal ECF No. 177 (MILLER,… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey | External link to document |
| 2016-03-21 | 185 | Response in Opposition to Motion | Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 (Attachments: # 1 Declaration of Bryan D… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey | External link to document |
| 2016-03-28 | 187 | Reply Brief to Opposition to Motion | Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 (Attachments: # 1 Certificate of Service… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey | External link to document |
| 2016-11-10 | 239 | Opinion | Tablets (“ZYTIGA®”): United States Patent Nos. 8,822,438 (the “438 patent” …abbreviated as follows: • ‘438 patent = Copy of U.S. Patent No. 8,822,438, Exhibit 1 to the Declaration…partes review (“IPR”) of the ‘438 patent, the Patent Office’s Patent Trial and Appeal Board (“PTAB”) construed… 2 BTG owns the ‘213 patent and Janssen Oncology owns the ‘438 patent. The Janssen plaintiffs are…seeking to add patent infringement claims against certain of the Defendants as to U.S. Patent No. 8,236,946 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
